Jason Herpel
About Jason Herpel
Jason Herpel serves as Vice President & Counsel at EyePoint Pharmaceuticals, where he has worked since 2022. He has extensive experience in various sectors, including biotech and healthcare, and holds advanced degrees in law and journalism.
Work at EyePoint Pharmaceuticals
Jason Herpel serves as Vice President & Counsel at EyePoint Pharmaceuticals, a position he has held since 2022. He is based in Watertown, Massachusetts, United States. In this role, he is involved in various legal and strategic initiatives that support the company's objectives in the pharmaceutical industry.
Education and Expertise
Jason Herpel has a strong educational background with a Bachelor of Arts degree in Journalism and American History from Penn State University, achieved between 1995 and 1999. He furthered his education by obtaining a Juris Doctor (JD) from Penn State Dickinson Law from 2000 to 2003. He also earned a Master of Law (LL.M) in Mergers & Acquisitions, Securities & Financial Regulation from Georgetown University Law Center from 2016 to 2018.
Background
Jason Herpel has extensive experience in various sectors, including Biotech, Medical Device, Population Health, Life Sciences, and Healthcare. His career includes significant roles in both legal and business capacities, showcasing his diverse industry knowledge. He has worked in multiple locations, including Malvern, Pennsylvania, and has been involved in clinical research, manufacturing, and software development.
Professional Experience
Prior to his current role, Jason Herpel held several key positions. He was Vice President of Mergers & Acquisitions and Counsel at BioTelemetry, Inc. from 2014 to 2022. He also worked as a Board Observer at NewPace Ltd. from 2020 to 2022. Earlier in his career, he was an Associate at Weber Gallagher Simpson Stapleton Fires & Newby LLP from 2005 to 2010 and served as an Assistant District Attorney at the Philadelphia District Attorney's Office from 2003 to 2005.
Achievements
Throughout his career, Jason Herpel has led reimbursement and payor expansion efforts in both the private and public sectors. He has executed strategic transactions across multiple countries, including England, Denmark, Sweden, the Netherlands, and Switzerland, demonstrating his capability in international business dealings.